Vanguard Group
VRDN icon

Vanguard Group’s Viridian Therapeutics VRDN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$63M Sell
4,508,508
-54,592
-1% -$763K ﹤0.01% 2025
2025
Q1
$61.5M Sell
4,563,100
-31,949
-0.7% -$431K ﹤0.01% 2007
2024
Q4
$88.1M Buy
4,595,049
+174,952
+4% +$3.35M ﹤0.01% 1928
2024
Q3
$101M Buy
4,420,097
+1,074,366
+32% +$24.4M ﹤0.01% 1871
2024
Q2
$43.5M Buy
3,345,731
+111,452
+3% +$1.45M ﹤0.01% 2204
2024
Q1
$56.6M Buy
3,234,279
+233,331
+8% +$4.09M ﹤0.01% 2114
2023
Q4
$65.4M Buy
3,000,948
+552,933
+23% +$12M ﹤0.01% 2076
2023
Q3
$37.6M Sell
2,448,015
-148,629
-6% -$2.28M ﹤0.01% 2264
2023
Q2
$61.8M Buy
2,596,644
+466,411
+22% +$11.1M ﹤0.01% 2092
2023
Q1
$54.2M Buy
2,130,233
+15,239
+0.7% +$388K ﹤0.01% 2138
2022
Q4
$61.8M Buy
2,114,994
+258,194
+14% +$7.54M ﹤0.01% 2068
2022
Q3
$38.1M Buy
1,856,800
+445,898
+32% +$9.15M ﹤0.01% 2309
2022
Q2
$16.3M Buy
1,410,902
+470,325
+50% +$5.44M ﹤0.01% 2743
2022
Q1
$17.4M Buy
940,577
+14,901
+2% +$276K ﹤0.01% 2850
2021
Q4
$18.3M Buy
925,676
+463,764
+100% +$9.17M ﹤0.01% 2887
2021
Q3
$7.6M Buy
461,912
+107,846
+30% +$1.77M ﹤0.01% 3404
2021
Q2
$6.48M Buy
354,066
+185,548
+110% +$3.39M ﹤0.01% 3449
2021
Q1
$2.82M Buy
168,518
+8,430
+5% +$141K ﹤0.01% 3782
2020
Q4
$2.63M Sell
160,088
-1,421,730
-90% -$23.4M ﹤0.01% 3591
2020
Q3
$1.23M Sell
1,581,818
-2,602
-0.2% -$2.02K ﹤0.01% 3612
2020
Q2
$1.76M Sell
1,584,420
-26,323
-2% -$29.2K ﹤0.01% 3465
2020
Q1
$718K Buy
1,610,743
+959,400
+147% +$428K ﹤0.01% 3585
2019
Q4
$312K Hold
651,343
﹤0.01% 3876
2019
Q3
$477K Buy
651,343
+33,429
+5% +$24.5K ﹤0.01% 3830
2019
Q2
$1.27M Buy
617,914
+169,086
+38% +$347K ﹤0.01% 3602
2019
Q1
$1.25M Buy
448,828
+19,932
+5% +$55.6K ﹤0.01% 3569
2018
Q4
$1.3M Sell
428,896
-434,450
-50% -$1.32M ﹤0.01% 3489
2018
Q3
$4.82M Sell
863,346
-8,925
-1% -$49.8K ﹤0.01% 3253
2018
Q2
$5.59M Buy
872,271
+56,269
+7% +$361K ﹤0.01% 3176
2018
Q1
$5.72M Buy
816,002
+408,390
+100% +$2.86M ﹤0.01% 3083
2017
Q4
$4.25M Buy
407,612
+364,147
+838% +$3.8M ﹤0.01% 3193
2017
Q3
$398K Buy
43,465
+2,278
+6% +$20.9K ﹤0.01% 3793
2017
Q2
$532K Buy
41,187
+30,749
+295% +$397K ﹤0.01% 3715
2017
Q1
$130K Hold
10,438
﹤0.01% 3966
2016
Q4
$53K Sell
10,438
-92,137
-90% -$468K ﹤0.01% 4026
2016
Q3
$50K Hold
102,575
﹤0.01% 4033
2016
Q2
$44K Sell
102,575
-33,536
-25% -$14.4K ﹤0.01% 4088
2016
Q1
$69K Sell
136,111
-36,650
-21% -$18.6K ﹤0.01% 4055
2015
Q4
$130K Hold
172,761
﹤0.01% 4058
2015
Q3
$160K Buy
172,761
+65,500
+61% +$60.7K ﹤0.01% 4052
2015
Q2
$235K Buy
107,261
+30,175
+39% +$66.1K ﹤0.01% 4020
2015
Q1
$166K Buy
+77,086
New +$166K ﹤0.01% 4022